TBPH icon

Theravance Biopharma

107 hedge funds and large institutions have $1.09B invested in Theravance Biopharma in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.12% less ownership

Funds ownership: 83.21%82.09% (-1.1%)

27% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 41

Holders
107
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.72M
Puts
$2.11M
Net Calls
Net Calls Change

Top Sellers

1 -$14.7M
2 -$8.8M
3 -$8.34M
4
Ameriprise
Ameriprise
Minnesota
-$6.74M
5
Norges Bank
Norges Bank
Norway
-$3.01M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$836K
52
$785K
53
$771K
54
$671K
55
$658K
56
$634K
57
$624K
58
$608K
59
$587K
60
$561K
61
$531K
62
$494K
63
$469K
64
$441K
65
$436K
66
$436K
67
$412K
68
$378K
69
$359K
70
$315K
71
$297K
72
$296K
73
$290K
74
$288K
75
$272K